An interventional study of Enhanced Recovery After Surgery and Usual Care in Gynecologic Surgery and General Anesthesia, sponsored by Wonju Severance Christian Hospital. Enrolling by invitation at 1 site in South Korea. Open to female participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Wonju Severance Christian Hospital · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery (ERAS) protocol in patients undergoing gynecologic laparoscopic or robotic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared with a historical control group?
Researchers will compare the prospective ERAS group with a historical control group using data from previously completed studies to evaluate whether the ERAS protocol improves the quality of recovery after surgery.
Participants in the prospective ERAS group will:
surgery, 24 hours after surgery, one week after discharge, and one month after discharge
Wonju Severance Christian Hospital is the lead sponsor of 43 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: Enhanced Recovery After Surgery
Procedure: Usual Care
1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a Foley catheter removal on ward arrival * Soft meal 4 hours after surgery * General diet 8 hours after surgery
Also known as: ERAS
1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery \- Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after surgery * Soft meal after gas out * General diet after one soft meal
Quality of Recovery-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
Time frame: 24 hours postoperatively
Quality of Recovery-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
Time frame: one week after hospital discharge
Quality of Recovery-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
Time frame: one month after hospital discharge
The World Health Organization Disability Assessment Schedule, Short Form (WHO-DAS)
The 12-item self-administered World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) assesses difficulties in functioning over the preceding 30 days. Each item is scored from 1 (no difficulty) to 5 (extreme difficulty or cannot do). The 12 item scores are summed to yield a total score ranging from 12 to 60, with higher scores indicating greater disability and poorer functioning.
Time frame: 24 hours postoperatively
The World Health Organization Disability Assessment Schedule, Short Form (WHO-DAS)
The 12-item self-administered World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) assesses difficulties in functioning over the preceding 30 days. Each item is scored from 1 (no difficulty) to 5 (extreme difficulty or cannot do). The 12 item scores are summed to yield a total score ranging from 12 to 60, with higher scores indicating greater disability and poorer functioning.
Time frame: one week after hospital discharge
The World Health Organization Disability Assessment Schedule, Short Form (WHO-DAS)
The 12-item self-administered World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) assesses difficulties in functioning over the preceding 30 days. Each item is scored from 1 (no difficulty) to 5 (extreme difficulty or cannot do). The 12 item scores are summed to yield a total score ranging from 12 to 60, with higher scores indicating greater disability and poorer functioning.
Time frame: one month after hospital discharge
EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
The EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) assesses health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is coded from 1 (no problems) to 5 (extreme problems or inability to perform the activity), with higher levels indicating more severe problems. The questionnaire also includes the EQ visual analogue scale (EQ VAS) for self-rated health. The EQ VAS ranges from 0 (the worst health imaginable) to 100 (the best health imaginable), with higher scores indicating better perceived health.
Time frame: 24 hours postoperatively
EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
The EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) assesses health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is coded from 1 (no problems) to 5 (extreme problems or inability to perform the activity), with higher levels indicating more severe problems. The questionnaire also includes the EQ visual analogue scale (EQ VAS) for self-rated health. The EQ VAS ranges from 0 (the worst health imaginable) to 100 (the best health imaginable), with higher scores indicating better perceived health.
Time frame: one week after hospital discharge
EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
The EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) assesses health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is coded from 1 (no problems) to 5 (extreme problems or inability to perform the activity), with higher levels indicating more severe problems. The questionnaire also includes the EQ visual analogue scale (EQ VAS) for self-rated health. The EQ VAS ranges from 0 (the worst health imaginable) to 100 (the best health imaginable), with higher scores indicating better perceived health.
Time frame: one month after hospital discharge
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Time frame: 24 hours postoperatively
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Time frame: 1 week after hospital discharge
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Time frame: 1 month after hospital discharge
Length of stay
Time frame: throughout hospitalization, expected to be 2-3 days
Total in-hospital opioid consumption
opioid consumption to alleviate pain; exclude intraoperative remifentanil
Time frame: throughout hospitalization, expected to be 2-3 days
Complication
Time frame: From enrollment to one month after discharge
Readmission
All-cause hospital readmission within 30 days after discharge, defined as any unplanned inpatient admission to any hospital
Time frame: From enrollment to one month after discharge
Heart rate variability
measured from wearable electrocardiography and a smart watch
Time frame: From discharge day to one month after discharge
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wonju Severance Christian Hospital